QT Interval Prolongation in People Treated With Bedaquiline for Drug-Resistant Tuberculosis Under Programmatic Conditions: A Retrospective Cohort Study.
Sharon IsrallsKathy J BaisleyEric NgamAlison D GrantJames D MillardPublished in: Open forum infectious diseases (2021)
We observed a modest prolongation of QTcF, maximal at week 15; there were no recorded arrhythmias or related deaths.
Keyphrases
- drug resistant
- drug induced
- multidrug resistant
- acinetobacter baumannii
- mycobacterium tuberculosis
- adverse drug
- heart rate
- resistance training
- congenital heart disease
- pulmonary tuberculosis
- hiv aids
- randomized controlled trial
- clinical trial
- blood pressure
- pseudomonas aeruginosa
- human immunodeficiency virus
- cystic fibrosis
- hiv infected
- study protocol